In addition, previous studies have reported that sesamin can suppress hepatocellular carcinoma cells via p53/p21-associated STAT3 signaling 19 and non-small cell lung cancer cells via the AKT-mediated p53 pathway 20. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.